Trial Profile
A Randomized Open-label Trial Cross-over Trial of Iron Isomaltoside 1000 (Monofer) Compared With Iron Sucrose (Venofer) in Peritoneal Dialysis Patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary) ; Iron sucrose
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 28 Sep 2021 Status changed from recruiting to discontinued as there is difficulty in patient recruitment due to COVID-19 epidemic
- 30 Apr 2019 Status changed from not yet recruiting to recruiting.
- 07 Aug 2018 New trial record